Corvus Pharmaceuticals Inc buy Barclays PLC
Start price
20.01.26
/
50%
€18.30
Target price
20.01.27
-
Performance (%)
-14.10%
Price
06.02.26
€15.74
Summary
This prediction is currently active. The price of Corvus Pharmaceuticals Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.10%. This prediction currently runs until 20.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | - |
| iShares Core DAX® | 0.463% |
| iShares Nasdaq 100 | -1.792% |
| iShares Nikkei 225® | 5.124% |
| iShares S&P 500 | -1.760% |
Comments by Barclays_PLC for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for CRVS provided by MarketBeat